ESC 365 - Doctor Tjasa Furlan

Speaker illustration

Doctor Tjasa Furlan

Trbovlje General Hospital, Trbovlje (Slovenia)

Member of:

Heart Failure Association of the ESC

Optimising heart failure therapy: potassium binders and the initiation and titration of mineralocorticoid receptor antagonists

Event: Heart Failure 2025

Topic: Pharmacotherapy

Session: ePosters in chronic heart failure - pharmacotherapy (3)

Use of non-diuretic pharmacological heart failure therapies in advanced heart failure patients with persistent congestion treated with sustained low-efficiency dialysis

Event: Heart Failure 2025

Topic: Nonpharmacological Treatment

Session: Guideline recommended treatment in acute heart failure

Hospital admissions and long-term outcomes in advanced heart failure patients with persistent congestion treated with sustained low-efficiency dialysis

Event: Heart Failure 2025

Topic: Nonpharmacological Treatment

Session: Updates in advanced and acute heart failure

Use of guideline-directed medical therapy in women hospitalised for decompensated heart failure

Event: Heart Failure 2024

Topic: Pharmacotherapy

Session: ePosters in acute heart failure 12

Initiation of sodium-glucose co-transporter-2 inhibitors in patients with heart failure in the acute medical setting

Event: Heart Failure 2024

Topic: Pharmacotherapy

Session: ePosters in chronic heart failure - pharmacotherapy 4

Factors influencing the recovery of ejection fraction in heart failure with reduced ejection fraction

Event: Heart Failure 2024

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Chronic heart failure - pathophysiology and mechanisms 13

Use of guideline-directed therapy in patients hospitalised at a general internal medicine ward

Event: Heart Failure 2024

Topic: Pharmacotherapy

Session: ePosters in chronic heart failure - pharmacotherapy 2

The difference in the use of guideline-directed medical therapy in patients hospitalised for heart failure managed by cardiologists and non-cardiologists

Event: Heart Failure 2024

Topic: Pharmacotherapy

Session: ePosters in chronic heart failure - pharmacotherapy 2

The effect of intravenous iron supplementation on handgrip strength in patients with heart failure

Event: Heart Failure 2023

Topic: Comorbidities

Session: ePosters in chronic heart failure - comorbidities 2

Dose-dependent impact of sacubitril/valsartan on left ventricular ejection fraction and survival in patients with heart failure with reduced ejection fraction

Event: Heart Failure 2022

Topic: Pharmacotherapy

Session: Heart Failure ePosters - focus on Chronic Heart Failure 5

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources